Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Epitopea logo

Epitopea

Recent Finacing

Pre-Series A

Recent Raise

$31M

Epitopea is a Cambridge- and Montreal-based biotech that discovers aberrantly expressed, broadly shared tumor-specific Cryptigen antigens via its CryptoMap immunopeptidomics/genomics platform and develops RNA vaccines, TCR and cell therapies.

Founded 2021
Cambridgeshire, United Kingdom
11-50
Private
epitopea.com

Highlights

Focus Areas

Biotechnology
Life Science
Therapeutics

Recent Investors

Harrington Discovery Institute logo
Cambridge Innovation Capital logo
Novateur Ventures logo
CTI Life Sciences Fund logo
Advent Life Sciences logo
Fonds de solidarit FTQ logo
adMare BioInnovations logo
IRICoR logo
Investissement Québec logo
Innovate UK logo

Financials

$44.8M

Total Raised

3

Funding rounds

10

Investors